Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma

British Journal of Surgery

Volumn 97, Issue 7, 2010, Pages 1020-1027

  Howard, J M ^a   Beddy, P ^a   Ennis, D ^a   Keogan, M ^a   Pidgeon, G P ^a   Reynolds, J V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN RECEPTOR; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN; LEPTIN RECEPTOR;

ABDOMINAL OBESITY; ADENOCARCINOMA; ARTICLE; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS TUMOR; FEMALE; HUMAN; INTRAABDOMINAL FAT; LOWER ESOPHAGUS SPHINCTER; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ADENOCARCINOMA; ADIPOKINES; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NEOPLASM STAGING; OBESITY, ABDOMINAL; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN; UP-REGULATION;

EID: 77953643031     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7072     Document Type: Article

References (48)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847-2850.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from, cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638. (Pubitemid 36459468)
3. Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc NutrSoc 2008; 67: 128-145.
4. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.' (Pubitemid 351232031)
5. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global, perspective. Proc Nutr Soc 2008; 67: 253-256.
6. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22.
7. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94: 1221-1225.
8. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432. (Pubitemid 24365442)
9. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 11.55-1161.
10. Bjørbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor .J. Biol Chem 1997; 272: 32 686-32 695.
11. Sweeney G. Leptin signalling. Cell Signal 2002; 14: 655-663.
12. Ogunwobi. OO, Beales IL. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and. Tgfalpha mediated transactivation of the epidermal growth factor receptor. Br J Biomed Sci 2008; 65: 121-127.
13. Somasundar P, Riggs D, Jackson B, Vona-Davis L, McFadden DW. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. AmJ Surg 2003; 186:575-578. (Pubitemid 37352849)
14. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 2005; 54: 1136-1145. (Pubitemid 41025909)
15. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK et al. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial, growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 2006; 281: 26 320-26 328.
16. Liu Z, Uesaka T, Watanabe H, Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 2001; 19: 1009-1014.
17. Kendall BJ, Macdonald. GA, Hayward NK, Prins JB, Brown I, Walker N et al. Leptin and the risk of Barrett's oesophagus. Gut 2008; 57: 448-454.
18. Stattin P, Palmqvist R, Söderberg S, Biessy C, Ardnor B, Hallmans G et al. Plasma leptin and colorectal cancer risk: a prospective study in Normern Sweden. Oncol Rep 2003; 10: 2015-2021.
19. Tamakoshi K, Toyoshima H, Wakai K, Kojima M, Suzuki K, Watanabe Y et al. Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology 2005; 68: 454-461. (Pubitemid 41160977)
20. Nishida M, Funahashi T, Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol 2007; 40: 55-67.
21. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451.
22. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 2008; 53: 597-605.
23. Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008; 285: 43-50.
24. Yildirim A, Bilici M, Cayir K, Yanmaz V, Yildirim S, Tekin SB. Serum adiponectin levels in patients with esophageal cancer. Jpn J Clin Oncol2009; 39: 92-96.
25. Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB et al. Association of adiponectin multimers with Barrett's esophagus. Gut 2009; 58: 1583-1589.
26. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005; 11: 466-472.
27. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 1688-1694.
28. Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer 2008; 15: 289-299.
29. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A et al. Total and high-molecularweight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2007; 92: 1041-1048.
30. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459.
31. American Joint Committee on Cancer. AJCC Cancer Staging Manual. Springer: New York, 2002.
32. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
33. Baumgartner RN, Heymsfield SB, Roche AF, Bernardino M. Abdominal composition quantified by computed tomography. AmJ Clin Nutr 1988; 48: 936-945.
34. Després JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993; 6: 137-159.
35. Rockett JC, Larldn K, Darnton SJ, Morris AG, Matthews HR. Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br J Cancer 1997; 75: 258-263.
36. Applied Biosystems. User Bulletin No. 2. Relative Quantification of Gene Expression. Applied Biosystems: Foster City, 1997.
37. Révillion F, Charlier M, Lhotellier V, Hornez L, Giard S, Baranzelli MC et al. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 2006; 12: 2088-2094.
38. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467.
39. Garofalo C, Koda M, Caseio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006; 12: 1447-1453.
40. Koda M, Sulkowska M, Kanczuga-Koda L, Caseio S, Colucci G, Russo A et al. Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer. Ann Oncol 2007; 18(Suppl 6):vi116-vi119.
41. Ishikawa M, Kitayama J, Nagawa H. Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J Gastroenterol 2006; 12: 5517-5522.
42. Zhao X, Huang K, Zhu Z, Chen S, Hu R. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer. J Gastroenterol Hepatol 2007; 22: 1317-1321.
43. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001; 33: 95-102.
44. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
45. Housa D, Housová J, Vernerová Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006; 55: 233-244.
46. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.
47. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004; 279: 1304-1309. (Pubitemid 38082655)
48. Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res 2009; 15: 3256-3264.